Randomised controlled Evaluation of Home treatment for Older People with Mental Illness

ISRCTN ISRCTN03613183
DOI https://doi.org/10.1186/ISRCTN03613183
Secondary identifying numbers N0195177177
Submission date
29/09/2006
Registration date
29/09/2006
Last edited
05/10/2011
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr James Warner
Scientific

Psychiatry
Imperial College London, Charing Cross Campus
Claybrook Centre, St Dunstans Road
Hammersmith
London
W6 8RP
United Kingdom

Phone +44 07970 849818
Email j.warner@imperial.ac.uk

Study information

Study designRandomised controlled parallel group trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study objectives1. By means of a randomised controlled trial. We will evaluate the impact of home treatment of older individuals with severe mental illness on: A. bed occupancy and admission rates. B. satisfaction, Quality of life and Mental Health. C. Adverse outcomes. D. Mental Health and quality of life of carers.
2. By means of a cross-sectional survey using a semi-structured interview with purposive sampling, we will identify stakeholder views on the home treatment service with particular emphasis on: A. Problems with introduction of home treatment in this service. B. Issues of establishing home treatment to other services.
3. Using a combination of qualitative and quantitative data from (1) and (2) above, we will ascertain those elements of the treatment service that are judged to be of value from the perspective of service providers and consumers. The null Hypothesis for the study is that intensive home treatment of older people with mental illness confers no advantages in terms of outcome, satisfaction, quality of life or costs compared with usual care.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedMental and Behavioural Disorders: Mental illness
InterventionParticipants will be recruited to the study at the point an admission is considered by the clinicians and randomised to home treatment as usual (2:1). Treatment will be for up to 8 weeks and participants will be evaluated at baseline, 8 weeks and 6 months.
Delivery of a multi-disciplinary intensive home treatment service versus usual care.

Added 21 August 2008: the trial was stopped in August 2005 due to very poor recruitment.
Intervention typeOther
Primary outcome measure1. Administrative data, mental health, quality of life
2. Psychiatric hospital bed days
3. Proportion of patients admitted
Secondary outcome measures1. Quality of Life (EQ5D)
2. Functioning (Global Assessment Functioning Scale)
3. Partnerships in Care (Helping Alliances)
4. Poly pharmacy medication proforma
5. Service Utilisation (proforma)
6. Residency
Overall study start date01/03/2005
Completion date28/02/2006
Reason abandoned (if study stopped)Poor recruitment

Eligibility

Participant type(s)Patient
Age groupSenior
SexNot Specified
Target number of participants50 outpatients
Key inclusion criteria1. Age 65 and over living in North Kensington or Westminster
2. Able to give informed consent (or assent if unable to give real consent)
3. Adequate English to complete questionnaires
4. The participant meets the operational criteria for admission to the home treatment team which is mental illness/impairment or personality disorder with one or more of the following:
4.1 Risk of suicide/self harm, self neglect,harm to others and or loss of contact to the service
4.2.Non-adherence to therapy
4.3 Institution of new therapy
4.4 Stabilisation of mental state
4.5 Observation of mental state
4.6 Relief/respite for carers
4.7 Faciltate early discharge
Key exclusion criteriaAdmission to continuing care or long term in-patient.
Date of first enrolment01/03/2005
Date of final enrolment28/02/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Psychiatry
London
W6 8RP
United Kingdom

Sponsor information

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Government

The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

London West Mental Health R&D Consortium, CNWL Mental Health Trust (UK)

No information available

NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan